Hardy W. Chan
Präsident bei ScinoPharm (Kunshan) Biochemical Technology Co., Ltd.
Profil
Hardy W.
Chan was the founder and had founded ScinoPharm Taiwan Ltd.
in 1997, where he held the title of Chief Scientific Officer & EVP until 2012.
He is currently working as an Adjunct Professor at National Cheng Kung University since 2010 and as the President of ScinoPharm (Kunshan) Biochemical Technology Co., Ltd.
Dr. Chan has previously worked as the Chief Executive Officer at Tanvex BioPharma USA, Inc., as well as the VP-Research & Director-Biotechnology at Syntex Corp.
and as a Director at Vita Genomics, Inc. He completed his undergraduate and doctorate degrees at the University of Wisconsin.
Aktive Positionen von Hardy W. Chan
| Unternehmen | Position | Beginn |
|---|---|---|
| National Cheng Kung University | Corporate Officer/Principal | - |
| ScinoPharm (Kunshan) Biochemical Technology Co., Ltd. | Präsident | 09.11.2010 |
Ehemalige bekannte Positionen von Hardy W. Chan
| Unternehmen | Position | Ende |
|---|---|---|
| Tanvex BioPharma USA, Inc. | Vorstandsvorsitzender | - |
| Syntex Corp. | Corporate Officer/Principal | - |
Vita Genomics, Inc.
 Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Direktor/Vorstandsmitglied | - |
| SCINOPHARM TAIWAN, LTD. | Gründer | - |
Ausbildung von Hardy W. Chan
| University of Wisconsin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SCINOPHARM TAIWAN, LTD. | Health Technology |
| Private Unternehmen | 4 |
|---|---|
| Syntex Corp. | Health Technology |
Vita Genomics, Inc.
Vita Genomics, Inc. Medical/Nursing ServicesHealth Services Vita Genomics, Inc. provides drug research services. It operates as a genomics-based biotechnological and biopharmaceutical company. The firm focuses on conducting pharmacogenomics research, in vitro diagnosis product development, and specialty contract research services in both genomics and pharmacogenomics fields. It offers advanced molecular diagnostic products and services, revolutionizing the drug-development process and providing pharmacogenomic solutions. The company was founded in March 2001 and is headquartered in New Taipei City, Taiwan. | Health Services |
| ScinoPharm (Kunshan) Biochemical Technology Co., Ltd. | |
| Tanvex BioPharma USA, Inc. |
